News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

3M Pharmaceuticals (MMM) Aldara (Imiquimod) Cream, 5% Included In Multiple Poster Presentations At American Academy Of Dermatology's ACADEMY 06 Meeting



7/27/2006 2:44:32 PM

ST. PAUL, Minn.--(BUSINESS WIRE)--July 27, 2006--3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology's (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external genital and perianal warts. The prescription therapy works by stimulating the skin's immune response to clear diseased or damaged cells.

Read at press release

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES